Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise / Aydin, S. Z.; Direskeneli, H.; Merkel, P. A.; Toloza, S.; Blockmans, D.; Sato, E. I.; De Souza, A. W. S.; Cabral, D.; Carette, S.; Famorca, L.; Khalidi, N.; Milman, N.; Yacyshyn, E.; Tesar, V.; Baslund, B.; Faurschou, M.; Guillevin, L.; Puechal, X.; Aries, P.; Hellmich, B.; Herlyn, K.; Holle, J.; Lamprecht, P.; Moosig, F.; Neumann, T.; Zwerina, J.; Tomasson, G.; Bambery, P.; Jois, R.; Rajasekhar, L.; Sharma, A.; Sivakumar, R.; Molloy, E.; Hashkes, P.; Catapano, F.; Cimino, L.; De Fanti, A.; Pipitone, N.; Salvarani, C.; Vaglio, A.; Kobayashi, S.; Suzuki, K.; Flores-Suarez, L. F.; Hinojosa-Azaola, A.; Brouwer, E.; Rutgers, A.; Stegeman, C.; Suppiah, R.; Hollan, I.; Arguis, P.; Cid, M. C.; Daikeler, T.; Alibaz-Oner, F.; Hamuryudan, V.; Hatemi, G.; Hazirolan, T.; Inanc, M.; Kalayci, M. B.; Kamali, S.; Kansu, T.; Karaaslan, Y.; Karadag, O.; Keser, G.; Onat, A. M.; Ozbalkan, Z.; Ozen, S.; Ozer, H. T. E.; Pamuk, O. N.; Yilmaz, S. G.; Basu, N.; Casian, A.; Chakravarty, K.; D'Cruz, D.; Edelsten, C.; Harper, L.; Jayne, D.; Levy, J.; Mason, J.; Robson, J.; Scott, D.; Stanford, M.; Watts, R.; Albert, D.; Amudala, N.; Beckman, J.; Chacko, B.; Chung, S.; Fessler, B.; Giardino, A.; Grayson, P.; Hunder, G.; Langford, C.; Lerman, M.; Liang, K.; Litt, H.; Mason, T.; Matteson, E.; Mikdashi, J.; Mohler, E.; Monach, P.; Rice, B.; Sharma, A.; Sreih, A.; Stone, J.; Tsapatsaris, N.; Villa-Forte, A.; Warrington, K.; Yazici, Y.; Ytterberg, S.. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 44:12(2017), pp. 1928-1932. [10.3899/jrheum.161269]
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise
Aydin S. Z.;Direskeneli H.;Merkel P. A.;Toloza S.;Blockmans D.;Sato E. I.;De Souza A. W. S.;Cabral D.;Carette S.;Famorca L.;Khalidi N.;Milman N.;Yacyshyn E.;Tesar V.;Baslund B.;Faurschou M.;Guillevin L.;Puechal X.;Aries P.;Hellmich B.;Herlyn K.;Holle J.;Lamprecht P.;Moosig F.;Neumann T.;Zwerina J.;Tomasson G.;Bambery P.;Jois R.;Rajasekhar L.;Sharma A.;Sivakumar R.;Molloy E.;Hashkes P.;Catapano F.;Cimino L.;De Fanti A.;Pipitone N.;Salvarani C.;Vaglio A.;Kobayashi S.;Suzuki K.;Flores-Suarez L. F.;Hinojosa-Azaola A.;Brouwer E.;Rutgers A.;Stegeman C.;Suppiah R.;Hollan I.;Arguis P.;Cid M. C.;Daikeler T.;Alibaz-Oner F.;Hamuryudan V.;Hatemi G.;Hazirolan T.;Inanc M.;Kalayci M. B.;Kamali S.;Kansu T.;Karaaslan Y.;Karadag O.;Keser G.;Onat A. M.;Ozbalkan Z.;Ozen S.;Ozer H. T. E.;Pamuk O. N.;Yilmaz S. G.;Basu N.;Casian A.;Chakravarty K.;D'Cruz D.;Edelsten C.;Harper L.;Jayne D.;Levy J.;Mason J.;Robson J.;Scott D.;Stanford M.;Watts R.;Albert D.;Amudala N.;Beckman J.;Chacko B.;Chung S.;Fessler B.;Giardino A.;Grayson P.;Hunder G.;Langford C.;Lerman M.;Liang K.;Litt H.;Mason T.;Matteson E.;Mikdashi J.;Mohler E.;Monach P.;Rice B.;Sharma A.;Sreih A.;Stone J.;Tsapatsaris N.;Villa-Forte A.;Warrington K.;Yazici Y.;Ytterberg S.
2017
Abstract
Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1207621
Citazioni
6
23
22
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. L’Università di Modena e Reggio Emilia non si assume alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione.